Two tumour necrosis factor receptors: structure and function.
暂无分享,去创建一个
W. Fiers | P. Vandenabeele | W. Fiers | R. Beyaert | W. Declercq | P Vandenabeele | W Declercq | W Fiers | R Beyaert
[1] C. Ware,et al. TNF receptor signal transduction. Ligand-dependent stimulation of a serine protein kinase activity associated with (CD120a) TNFR60. , 1994, Journal of Immunology.
[2] M. Boguski,et al. A novel RING finger protein interacts with the cytoplasmic domain of CD40. , 1994, The Journal of biological chemistry.
[3] H. Loetscher,et al. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors , 1990, The Journal of experimental medicine.
[4] L. Tartaglia,et al. A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.
[5] M. Gerhart,et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing , 1994, Nature.
[6] S. Nagata,et al. The Fas death factor , 1995, Science.
[7] H. Loetscher,et al. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55 , 1993, The Journal of experimental medicine.
[8] S. Nagata,et al. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.
[9] F. Porteu,et al. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. , 1994, The Journal of biological chemistry.
[10] W. Schmiegel,et al. Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA. , 1993, The Journal of biological chemistry.
[11] P. Vassalli,et al. The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.
[12] W. Fiers,et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis , 1995, Nature.
[13] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[14] K. Hsu,et al. Differential expression and ligand binding properties of tumor necrosis factor receptor chimeric mutants. , 1993, The Journal of biological chemistry.
[15] D. Goeddel,et al. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75 , 1995, The Journal of experimental medicine.
[16] P. Vandenabeele,et al. Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor. , 1994, European journal of biochemistry.
[17] L. Tartaglia,et al. Two TNF receptors. , 1992, Immunology today.
[18] L. Gooding,et al. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.
[19] C. Belka,et al. Tumor necrosis factor (TNF)‐alpha activates c‐raf‐1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. , 1995, The EMBO journal.
[20] D. Wallach,et al. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. , 1992, The EMBO journal.
[21] H. Loetscher,et al. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor , 1990, The Journal of experimental medicine.
[22] Sharad Kumar,et al. ICE-like proteases in apoptosis. , 1995, Trends in biochemical sciences.
[23] W. Fiers,et al. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. , 1995, Cytokine.
[24] W. Fiers,et al. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. , 1993, The American journal of pathology.
[25] D. Goeddel,et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice , 1994, Nature.
[26] J. Tavernier,et al. Structure-activity studies of human tumour necrosis factors. , 1994, Protein engineering.
[27] R. Gentz,et al. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. , 1992, Journal of immunology.
[28] W. Fiers. Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.
[29] D. Banner,et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.
[30] M. Krönke,et al. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling , 1994, Cell.
[31] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.
[32] R. Gentz,et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. , 1990, Cytokine.
[33] P. Scheurich,et al. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. , 1993, Lymphokine and cytokine research.
[34] C. Ware,et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.
[35] D. Goeddel,et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.
[36] N. Fan,et al. The p70 tumor necrosis factor receptor mediates cytotoxicity , 1992, Cell.
[37] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[38] W. Fiers,et al. Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. , 1988, Journal of immunology.
[39] M. Tewari,et al. Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*) , 1995, The Journal of Biological Chemistry.
[40] S. Calvano,et al. A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon , 1994, The Journal of experimental medicine.
[41] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.
[42] P. Vandenabeele,et al. Generation and Biological Characterization of Membrane-bound, Uncleavable Murine Tumor Necrosis Factor (*) , 1995, The Journal of Biological Chemistry.
[43] D. Donner,et al. Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. , 1994, Journal of Biological Chemistry.
[44] H. Steller. Mechanisms and genes of cellular suicide , 1995, Science.
[45] P. Leder,et al. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.
[46] W. Fiers,et al. Tumor necrosis factor : molecular and cellular biology and clinical relevance , 1993 .
[47] W. Fiers,et al. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. , 1995, Journal of immunology.
[48] J. Camonis,et al. Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (*) , 1995, The Journal of Biological Chemistry.
[49] I. Beletsky,et al. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity , 1994, The Journal of experimental medicine.
[50] J. Chant,et al. GTPase cascades choreographing cellular behavior: Movement, morphogenesis, and more , 1995, Cell.
[51] T. Mak,et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.
[52] S. Nagata,et al. Involvement of an ICE-like protease in Fas-mediated apoptosis , 1995, Nature.
[53] Yuan Zhang,et al. Identification of a Protein with Homology to hsp90 That Binds the Type 1 Tumor Necrosis Factor Receptor (*) , 1995, The Journal of Biological Chemistry.
[54] J. Cleveland,et al. Contenders in FasL/TNF death signaling , 1995, Cell.
[55] W. Fiers,et al. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma , 1992, The Journal of experimental medicine.
[56] B. Aggarwal,et al. Physical and functional association of a serine-threonine protein kinase to the cytoplasmic domain of the p80 form of the human tumor necrosis factor receptor in human histiocytic lymphoma U-937 cells. , 1994, The Journal of biological chemistry.
[57] D. Goeddel,et al. Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation. , 1992, The Journal of biological chemistry.
[58] W. Fiers,et al. Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines. , 1986, Cellular immunology.
[59] V. Devita,et al. Biologic Therapy of Cancer , 1992 .
[60] Jan Tavernier,et al. Human TNF mutants with selective activity on the p55 receptor , 1993, Nature.
[61] William B. Smith,et al. Dissociation of TNF‐alpha cytotoxic and proinflammatory activities by p55 receptor‐ and p75 receptor‐selective TNF‐alpha mutants. , 1994, The EMBO journal.
[62] L. Tartaglia,et al. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.
[63] R. Zinkernagel,et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.
[64] Muneesh Tewari,et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.
[65] R. Gentz,et al. Genomic organization and promoter function of the murine tumor necrosis factor receptor β gene , 1993 .
[66] W. Fiers,et al. Molecular mechanisms of tumor necrosis factor‐induced cytotoxicity , 1994, FEBS letters.
[67] B. Aggarwal,et al. Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. , 1994, The Journal of biological chemistry.
[68] C. Perez,et al. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.
[69] D. Banner,et al. Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. , 1993, The Journal of biological chemistry.
[70] D. Baltimore,et al. Involvement of CRAF1, a relative of TRAF, in CD40 signaling , 1995, Science.
[71] U. Gullberg,et al. Modulation of the constitutive gene expression of the 55 kD tumor necrosis factor receptor in hematopoietic cells. , 1990, Biochemical and biophysical research communications.
[72] B. Beutler,et al. Unraveling function in the TNF ligand and receptor families. , 1994, Science.
[73] J. Tainer,et al. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis , 1990, Cell.
[74] M. Tewari,et al. The Baculovirus p35 Protein Inhibits Fas- and Tumor Necrosis Factor-induced Apoptosis (*) , 1995, The Journal of Biological Chemistry.